The evolution of cardiovascular stent materials and surfaces in response to clinical drivers: a review.

This review examines cardiovascular stent materials from the perspective of a range of clinical drivers and the materials that have been developed in response to these drivers. The review is generally chronological and outlines how stent materials have evolved from initial basic stainless steel devices all the way through to the novel biodegradable devices currently being explored. Where appropriate, pre-clinical or clinical data that influenced decisions and selections along the way is referenced. Opinions are given as to the merit and direction of various ongoing and future developments.

[1]  J. Tanigawa,et al.  Coronary bioabsorbable magnesium stent: 15-month intravascular ultrasound and optical coherence tomography findings. , 2007, European heart journal.

[2]  C. Di Mario,et al.  Comparison of diamond-like carbon-coated stents versus uncoated stainless steel stents in coronary artery disease. , 2004, The American journal of cardiology.

[3]  R. Günther,et al.  New Metallic MR Stents for Artifact-Free Coronary MR Angiography: Feasibility Study in a Swine Model , 2004, Investigative radiology.

[4]  B. Rutherford,et al.  Evaluation of the Medtronic (Driver) cobalt-chromium alloy coronary stent system. , 2005, The American journal of cardiology.

[5]  M. Metikoš-huković,et al.  Influence of alloying elements on the corrosion stability of CoCrMo implant alloy in Hank's solution. , 2006, Acta biomaterialia.

[6]  Giuseppe Musumeci,et al.  Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent: Should We Be Cautious? , 2004, Circulation.

[7]  W. Carroll,et al.  Development of a new niobium-based alloy for vascular stent applications. , 2008, Journal of the mechanical behavior of biomedical materials.

[8]  Usefulness of a cobalt chromium coronary stent alloy. , 2003 .

[9]  G. Stone,et al.  Clinical ResearchInterventional CardiologyIncidence, Timing, and Correlates of Stent Thrombosis With the Polymeric Paclitaxel Drug-Eluting Stent: A TAXUS II, IV, V, and VI Meta-Analysis of 3,445 Patients Followed for Up to 3 Years , 2007 .

[10]  J. Airaksinen,et al.  Titanium and nitride oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population. , 2006, The Journal of invasive cardiology.

[11]  S. Teoh,et al.  Development of nitrogen-containing nickel-free austenitic stainless steels for metallic biomaterials—review , 2004 .

[12]  G. Chatellier,et al.  Strecker stent implantation in iliac arteries: patency and predictive factors for long-term success. , 1995, Radiology.

[13]  A. Hotta,et al.  Fluorine doping into diamond-like carbon coatings inhibits protein adsorption and platelet activation. , 2007, Journal of biomedical materials research. Part A.

[14]  G. Meireles,et al.  Randomized comparative study of diamond-like carbon coated stainless steel stent versus uncoated stent implantation in patients with coronary artery disease. , 2007, Arquivos brasileiros de cardiologia.

[15]  M. Gyöngyösi,et al.  First in–human randomized comparison of an anodized niobium stent versus a standard stainless steel stent , 2006, Clinical Research in Cardiology.

[16]  O. Hess,et al.  Stent Coating With Titanium-Nitride-Oxide for Reduction of Neointimal Hyperplasia , 2001, Circulation.

[17]  Sung Joon Park,et al.  Controlled drug release using nanoporous anodic aluminum oxide on stent , 2007 .

[18]  A. Kastrati,et al.  Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. , 2000, Circulation.

[19]  Philipp Beerbaum,et al.  Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta. , 2006, Biomaterials.

[20]  N. Weissman,et al.  Randomized comparison of carbon ion-implanted stent versus bare metal stent in coronary artery disease: the Asian Pacific Multicenter Arthos Stent Study (PASS) trial. , 2005, American Heart Journal.

[21]  Christian W Hamm,et al.  Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis , 2000, The Lancet.

[22]  J. D. Robertson,et al.  Long-term stability of a coronary stent coating post-implantation. , 2002, Journal of biomedical materials research.

[23]  P. Fitzgerald,et al.  Drug delivery via nano-, micro and macroporous coronary stent surfaces , 2007, Expert opinion on drug delivery.

[24]  P. Serruys,et al.  A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial. , 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[25]  Michael Joner,et al.  Drug-Eluting Stent and Coronary Thrombosis: Biological Mechanisms and Clinical Implications , 2007, Circulation.

[26]  H. Plenk,et al.  The electrochemical behavior of metallic implant materials as an indicator of their biocompatibility. , 1987, Journal of biomedical materials research.

[27]  Jörg Hausleiter,et al.  Randomized Trial of a Nonpolymer-Based Rapamycin-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent for the Reduction of Late Lumen Loss , 2006, Circulation.

[28]  Matthias Stuber,et al.  Artifact-Free Coronary Magnetic Resonance Angiography and Coronary Vessel Wall Imaging in the Presence of a New, Metallic, Coronary Magnetic Resonance Imaging Stent , 2005, Circulation.

[29]  J. Palmaz,et al.  A Model System to Assess Key Vascular Responses to Biomaterials , 2005, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[30]  Ron Waksman,et al.  Short-term effects of biocorrodible iron stents in porcine coronary arteries. , 2008, Journal of interventional cardiology.

[31]  Ralf Degenhardt,et al.  Comparison of a silicon carbide-coated stent versus a noncoated stent in human beings: the Tenax versus Nir Stent Study's long-term outcome. , 2003, American heart journal.

[32]  Neville Kukreja,et al.  Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study , 2007, The Lancet.

[33]  S. Milz,et al.  Inhibition of Neointima Formation by a Novel Drug-Eluting Stent System That Allows for Dose-Adjustable, Multiple, and On-Site Stent Coating , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[34]  D. Antoniucci,et al.  Clinical and angiographic outcomes following elective implantation of the carbostent in patients at high risk of restenosis and target vessel failure , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[35]  Stefan Ulzheimer,et al.  In vitro evaluation of coronary stents and in-stent stenosis using a dynamic cardiac phantom and a 64-detector row CT scanner , 2007, Clinical Research in Cardiology.

[36]  Chan Jc,et al.  The CardioMind coronary stent delivery system: stent delivery on a .014" guidewire platform. , 2007 .

[37]  F. Clubb,et al.  Hydroxyapatite-coated cardiovascular stents. , 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[38]  R. Schwartz,et al.  Zotarolimus-eluting stents reduce experimental coronary artery neointimal hyperplasia after 4 weeks. , 2006, European heart journal.

[39]  Patrick W Serruys,et al.  A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial , 2008, The Lancet.

[40]  R. Virmani,et al.  A novel paclitaxel‐eluting porous carbon–carbon nanoparticle coated, nonpolymeric cobalt–chromium stent: Evaluation in a porcine model , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[41]  D. Boismier,et al.  Characterization of an NbTaWZr alloy designed for magnetic resonance angiography compatible stents. , 2008, Biomaterials.

[42]  P. Karjalainen,et al.  Real world experience with the TITAN(R) stent: a 9-month follow-up report from The Titan PORI Registry. , 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[43]  C. Beythien,et al.  In vitro analyses of diamond-like carbon coated stents. Reduction of metal ion release, platelet activation, and thrombogenicity. , 2000, Thrombosis research.

[44]  Martin Spahn,et al.  Flat detectors and their clinical applications , 2005, European Radiology.

[45]  R. Virmani,et al.  Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization , 2007, Circulation.

[46]  A. Kastrati,et al.  Intracoronary Stenting and Angiographic Results: Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial , 2001, Circulation.

[47]  G. Stone,et al.  Non–Polymer-Based Paclitaxel-Coated Coronary Stents for the Treatment of Patients With De Novo Coronary Lesions: Angiographic Follow-Up of the DELIVER Clinical Trial , 2004, Circulation.

[48]  C. Di Mario,et al.  MOONLIGHT: a controlled registry of an iridium oxide-coated stent with angiographic follow-up. , 2004, International journal of cardiology.

[49]  Raimund Erbel,et al.  Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial , 2007, The Lancet.

[50]  L. Cornish,et al.  Mechanical properties and microstructure of platinum enhanced radiopaque stainless steel (PERSS) alloys , 2003 .

[51]  P. J. Thompson,et al.  Assessment of wrought ASTM F1058 cobalt alloy properties for permanent surgical implants. , 1997, Journal of biomedical materials research.

[52]  Rainer Raupach,et al.  64-slice multidetector coronary CT angiography: in vitro evaluation of 68 different stents , 2006, European Radiology.

[53]  P. Pattynama,et al.  A precious metal alloy for construction of MR imaging-compatible balloon-expandable vascular stents. , 2001, Radiology.

[54]  Elazer R. Edelman,et al.  Gold-Coated NIR Stents in Porcine Coronary Arteries , 2001, Circulation.

[55]  W. J. van der Giessen,et al.  Polymers, drug release, and drug-eluting stents. , 2006, Journal of interventional cardiology.

[56]  Mitchell W. Krucoff,et al.  A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study. , 2008, Journal of the American College of Cardiology.

[57]  H. Oswald,et al.  Coronary arterial stents: safety and artifacts during MR imaging. , 2000, Radiology.

[58]  A. Lewis,et al.  Phosphorylcholine-based polymer coatings for stent drug delivery , 2001, Journal of materials science. Materials in medicine.

[59]  D. Leung,et al.  Contrast-enhanced MR angiography at 1.5 T after implantation of platinum stents: in vitro and in vivo comparison with conventional stent designs. , 2005, AJR. American journal of roentgenology.

[60]  Raimund Erbel,et al.  Drug-eluting bioabsorbable magnesium stent. , 2004, Journal of interventional cardiology.

[61]  C. Di Mario,et al.  In-stent restenosis in small coronary arteries: impact of strut thickness. , 2002, Journal of the American College of Cardiology.

[62]  R. Virmani,et al.  Drug-eluting versus bare metal coronary stents: long-term human pathology. Findings from different coronary arteries in the same patient. , 2003, Italian heart journal : official journal of the Italian Federation of Cardiology.

[63]  F. Eberli,et al.  Drug-eluting stents—what should be improved? , 2008, Annals of medicine.

[64]  C. Di Mario,et al.  Direct stenting of de novo coronary stenoses with tacrolimus-eluting versus carbon-coated carbostents. The randomized JUPITER II trial. , 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[65]  A. Kastrati,et al.  Influence of stent surface topography on the outcomes of patients undergoing coronary stenting: A randomized double‐blind controlled trial , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[66]  P. Vallance,et al.  Endothelial function and nitric oxide: clinical relevance , 2001, Heart.

[67]  A Haverich,et al.  Left main coronary artery fistula exiting into the right atrium , 2003, Heart.

[68]  S. Aziz,et al.  Clinical experience with the Wiktor stent in native coronary arteries and coronary bypass grafts. , 1994, British heart journal.

[69]  M. Viergever,et al.  MR imaging of vascular stents: effects of susceptibility, flow, and radiofrequency eddy currents. , 2001, Journal of vascular and interventional radiology : JVIR.

[70]  Takao Hanawa,et al.  Metal ion release from metal implants , 2004 .

[71]  Rüdiger Blindt,et al.  Coronary Artery Stents in Multislice Computed Tomography: In Vitro Artifact Evaluation , 2004, Investigative radiology.

[72]  W. J. van der Giessen,et al.  Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries , 2000, Heart.

[73]  G. Biondi-Zoccai,et al.  Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®) , 2008, Vascular health and risk management.

[74]  T. Norgaz,et al.  Is there a link between nickel allergy and coronary stent restenosis? , 2005, The Tohoku journal of experimental medicine.

[75]  M. Peuster,et al.  A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal—results 6–18 months after implantation into New Zealand white rabbits , 2001, Heart.

[76]  M. Eisenberg,et al.  Coated stents for the prevention of restenosis: Part I. , 2002, Circulation.

[77]  F. Crea,et al.  Effects of carbon-coated coronary stents on the markers of inflammation, thrombin generation and platelet and endothelial activation. , 2003, Italian heart journal : official journal of the Italian Federation of Cardiology.

[78]  J. Popma,et al.  Clinical and angiographic results of percutaneous coronary revascularization using a trilayer stainless steel‐tantalum‐stainless steel phosphorylcholine‐coated stent: The TriMaxx trial , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[79]  F. Eberli,et al.  Randomized Comparison of a Titanium-Nitride-Oxide–Coated Stent With a Stainless Steel Stent for Coronary Revascularization: The TiNOX Trial , 2005, Circulation.

[80]  S. Silber,et al.  The NUGGET study: NIR ultra gold‐gilded equivalency trial , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[81]  R. Erbel,et al.  Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.